You are viewing an incomplete version of our website. Please click to reload the website as full version.

anti-Coagulation Factor V (F5) Antibodies

F5 encodes an essential cofactor of the blood coagulation cascade. Additionally we are shipping Coagulation Factor V Kits (51) and Coagulation Factor V Proteins (22) and many more products for this protein.

list all antibodies Gene Name GeneID UniProt
F5 14067 O88783
F5 2153 P12259
F5 304929  
How to order from antibodies-online
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Order online

Top anti-Coagulation Factor V Antibodies at

Showing 10 out of 113 products:

Catalog No. Reactivity Host Conjugate Application Images Quantity Supplier Delivery Price Details
Human Mouse Un-conjugated ELISA, WB   100 μg Log in to see 3 to 4 Days
Human Rabbit Un-conjugated IF (p), IHC (p) Formalin-fixed and paraffin embedded rat heart labeled with Anti-factor V Polyclonal Antibody, Unconjugated (ABIN736776) at 1:200 followed by conjugation to the secondary antibody and DAB staining. 100 μL Log in to see 3 to 7 Days
Human Rabbit Un-conjugated ICC, IHC (fro), IHC (p), ELISA, WB 100 μg Log in to see 9 to 11 Days
Human Rabbit Un-conjugated ICC, IHC (fro), IHC (p), ELISA, WB 100 μg Log in to see 9 to 11 Days
Human Rabbit Un-conjugated ICC, IHC (fro), IHC (p), ELISA, WB 100 μg Log in to see 9 to 11 Days
Mouse Rabbit Un-conjugated ICC, IHC (fro), IHC (p), ELISA, WB 100 μg Log in to see 9 to 11 Days
Mouse Rabbit Un-conjugated ICC, IHC (fro), IHC (p), ELISA, WB 100 μg Log in to see 9 to 11 Days
Mouse Rabbit Un-conjugated ICC, IHC (fro), IHC (p), ELISA, WB 100 μg Log in to see 9 to 11 Days
Cow Rabbit Un-conjugated ICC, IHC (fro), IHC (p), ELISA, WB 100 μg Log in to see 9 to 11 Days
Human Rabbit Un-conjugated WB   200 μL Log in to see 9 Days

F5 Antibodies by Reactivity, Application, Clonality and Conjugate

Attributes Applications Host Clonality Conjugate
Mouse (Murine) , , ,

, , , , , , , , , , ,
Human , , , ,
, , ,
, , , , , , , , , , ,
Rat (Rattus) , ,

, , , , , , , , , , ,

More Antibodies against Coagulation Factor V Interaction Partners

Mouse (Murine) Coagulation Factor V (F5) interaction partners

  1. These findings reveal a novel biological function and mechanism of the protein C (show PROC Antibodies) pathway in which protein S and the aPC (show APC Antibodies)-cleaved form of fV are cofactors for anti-inflammatory cell signaling by aPC (show APC Antibodies) in the context of endotoxemia and infection

  2. Mice deficient in LMAN1 exhibit FV and FVIII deficiencies and liver accumulation of alpha1-antitrypsin.

  3. The FVL mutation does not influence coagulation activation, lung inflammation or survival in lethal influenza A.

  4. It suggested that there could be a combination of GLA (show GLA Antibodies) deficiency and FVL or other thrombosis-related gene defect in patients with genetic severe early-onset thrombosis.

  5. Data suggest that tissue factor (show F3 Antibodies) and factor V induction by LPS (show TLR4 Antibodies) may in part accelerate mesangioproliferative glomerulonephritis through activation of factor X and downstream proinflammatory and procoagulant mechanisms.

  6. The source of the FVL leading to accelerated thrombosis appears to be circulating, non-platelet-derived plasma FVL.

  7. FVL has the ability to improve the hemophilia A or B phenotype, but this effect is principally evident at the microcirculation level following a particular vascular injury.

  8. observations demonstrate a synergistic interaction between alpha-galactosidase A (show GLA Antibodies) deficiency and Factor V Leiden toward tissue fibrin deposition; concomitant mutations in these genes may increase the penetrance of vascular thrombotic events in humans

  9. Fetal gene defects precipitate platelet-mediated pregnancy failure in factor V Leiden mothers.

  10. The FVL mutation has no effect on the development of secondary tumours of colon cancer in livers of mice.

Human Coagulation Factor V (F5) interaction partners

  1. Factor V (F5) c.1691G>A (Leiden) was present in 0.5% of 400 ischemic stroke patients in Sri (show SRI Antibodies) Lanka. F5 mutation was present in a statistically significant number of patients with venous thrombosis (P = .005) compared to those with arterial thrombosis.

  2. The present data showed that FVL, MTHFR (show MTHFR Antibodies) polymorphisms also combined with thrombophilic gene mutations have a strong association with recurrent pregnancy loss.

  3. FVL has a modifying effect on PAI-1 (show SERPINE1 Antibodies) polymorphism in relation to risk of VTE recurrence.

  4. combination of FVL and MTHFR (show MTHFR Antibodies) mutation related to the risk of recurrent fetal death and habitual abortion

  5. Case Report: acquired FV inhibitor that developed in a patient after exposure to human thrombin (show F2 Antibodies) used as a hemostatic agent during an otorhinolaryngology surgical procedure.

  6. In the current study Factor V Leiden, prothrombin (show F2 Antibodies) G20210A, and thrombospondin-1 (show THBS1 Antibodies) polymorphisms showed no association with severity of hepatic fibrosis.

  7. Chromosomal abnormalities and abnormalities in the genes related to thrombophilia such as FVL, MTHFR (show MTHFR Antibodies) and PTm mutations may be considered as risk factors for RM [recurrent miscarriage]

  8. Given the essential role of platelet-derived factor Va in clot (show TXNDC17 Antibodies) formation, understanding the cellular and molecular mechanisms that regulate how platelets acquire this molecule will be important for the treatment of excessive bleeding or clotting

  9. the diagnosis of an 'unaffected' foetus was offered. The child was subsequently followed up after delivery and was found to be normal for factor V levels with a normal genotype

  10. Data (including data from case-control, genetic association studies) suggest that Factor V mutation Leiden is associated with significant genetic predisposition for venous thromboembolism (not thrombophilia) in pregnancy. [META-ANALYSIS, REVIEW]

Cow (Bovine) Coagulation Factor V (F5) interaction partners

  1. Data suggest factor Xa (FXa (show F10 Antibodies)) and factor Va (FVa) compete to bind FXa (show F10 Antibodies) on both PS model membranes and microparticles from activated platelets; this competition between dimerization/prothrombinase (show FGL2 Antibodies) complex formation appears to regulate blood coagulation.

Coagulation Factor V (F5) Antigen Profile

Protein Summary

This gene encodes an essential cofactor of the blood coagulation cascade. This factor circulates in plasma, and is converted to the active form by the release of the activation peptide by thrombin during coagulation. This generates a heavy chain and a light chain which are held together by calcium ions. The activated protein is a cofactor that participates with activated coagulation factor X to activate prothrombin to thrombin. Defects in this gene result in either an autosomal recessive hemorrhagic diathesis or an autosomal dominant form of thrombophilia, which is known as activated protein C resistance.

Gene names and symbols associated with F5

  • coagulation factor V (LOC100534566) antibody
  • coagulation factor V (F5) antibody
  • coagulation factor V (proaccelerin, labile factor) (F5) antibody
  • Ac2-120 antibody
  • AI173222 antibody
  • Cf-5 antibody
  • Cf5 antibody
  • FVL antibody
  • PCCF antibody
  • RPRGL1 antibody
  • THPH2 antibody

Protein level used designations for F5

coagulation factor V , activated protein C cofactor , activated protein c cofactor , coagulation factor V jinjiang A2 domain , factor V Leiden , proaccelerin, labile factor

100534566 Oreochromis niloticus
14067 Mus musculus
2153 Homo sapiens
304929 Rattus norvegicus
280687 Bos taurus
100715882 Cavia porcellus
397217 Sus scrofa
100685858 Canis lupus familiaris
101123649 Ovis aries
Selected quality suppliers for anti-Coagulation Factor V (F5) Antibodies
Did you look for something else?